 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Momenta Pharmaceuticals, Inc. MNTA or the Company NASDAQ: MNTA in connection with the proposed acquisition of the Company by Johnson Johnson JNJ NYSE: JNJ. Under the terms of the acquisition agreement, which is structured as a tender offer, MNTA shareholders will receive 52.50 in cash for each share of MNTA common stock that they own. 